These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36537129)

  • 1. External Validation of the United Kingdom Transplant Benefit Score in Australia and New Zealand.
    Lee EG; Perini MV; Makalic E; Oniscu GC; Fink MA
    Prog Transplant; 2023 Mar; 33(1):25-33. PubMed ID: 36537129
    [No Abstract]   [Full Text] [Related]  

  • 2. External validation of the US and UK kidney donor risk indices for deceased donor kidney transplant survival in the Australian and New Zealand population.
    Clayton PA; Dansie K; Sypek MP; White S; Chadban S; Kanellis J; Hughes P; Gulyani A; McDonald S
    Nephrol Dial Transplant; 2019 Dec; 34(12):2127-2131. PubMed ID: 31157885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in Australia and New Zealand.
    McCaughan GW; Munn SR
    Liver Transpl; 2016 Jun; 22(6):830-8. PubMed ID: 27028552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.
    Schlegel A; Kalisvaart M; Scalera I; Laing RW; Mergental H; Mirza DF; Perera T; Isaac J; Dutkowski P; Muiesan P
    J Hepatol; 2018 Mar; 68(3):456-464. PubMed ID: 29155020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival.
    Malik AK; Masson S; Allen E; Akyol M; Bathgate A; Davies M; Hidalgo E; Hudson M; Powell J; Taylor R; Zarankaite A; Manas DM;
    Transplantation; 2019 Nov; 103(11):2304-2311. PubMed ID: 30830042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPTN/SRTR 2018 Annual Data Report: Liver.
    Kwong A; Kim WR; Lake JR; Smith JM; Schladt DP; Skeans MA; Noreen SM; Foutz J; Miller E; Snyder JJ; Israni AK; Kasiske BL
    Am J Transplant; 2020 Jan; 20 Suppl s1():193-299. PubMed ID: 31898413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
    Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPTN/SRTR 2017 Annual Data Report: Liver.
    Kim WR; Lake JR; Smith JM; Schladt DP; Skeans MA; Noreen SM; Robinson AM; Miller E; Snyder JJ; Israni AK; Kasiske BL
    Am J Transplant; 2019 Feb; 19 Suppl 2():184-283. PubMed ID: 30811890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved waitlist and transplant outcomes for pediatric lung transplantation after implementation of the lung allocation score.
    Lancaster TS; Miller JR; Epstein DJ; DuPont NC; Sweet SC; Eghtesady P
    J Heart Lung Transplant; 2017 May; 36(5):520-528. PubMed ID: 27866928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Yi Z; Mayorga ME; Orman ES; Wheeler SB; Hayashi PH; Barritt AS
    Transplantation; 2017 Oct; 101(10):2368-2374. PubMed ID: 28858174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal validation of the Australian estimated post-transplant survival score.
    Irish GL; Campbell S; Kanellis J; Wyburn K; Clayton PA
    Nephrology (Carlton); 2023 May; 28(5):292-298. PubMed ID: 36941195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Mandatory 6-Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma.
    Nagai S; Kitajima T; Yeddula S; Salgia R; Schilke R; Abouljoud MS; Moonka D
    Hepatology; 2020 Dec; 72(6):2051-2062. PubMed ID: 32157711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons Learned From Review of a Single Center Experience With 500 Consecutive Liver Transplants in a Region With Insufficient Deceased-Donor Support.
    Yankol Y; Mecit N; Kanmaz T; Cimsit B; Cakaloglu Y; Acarli K; Kalayoglu M
    Exp Clin Transplant; 2016 Apr; 14(2):191-200. PubMed ID: 26030810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
    Nagai S; Chau LC; Kitajima T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation in the United Kingdom.
    Neuberger J
    Liver Transpl; 2016 Aug; 22(8):1129-35. PubMed ID: 27081833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Transplant Waitlist Outcomes and the Allocation of Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Points at a Low-Volume Center.
    Tan EK; Goh BKP; Lee SY; Krishnamoorthy TL; Tan CK; Jeyaraj PR
    Transplant Proc; 2018 Dec; 50(10):3564-3570. PubMed ID: 30577239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study.
    Rodríguez-Perálvarez ML; Gómez-Orellana AM; Majumdar A; Bailey M; McCaughan GW; Gow P; Guerrero M; Taylor R; Guijo-Rubio D; Hervás-Martínez C; Tsochatzis EA
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):242-252. PubMed ID: 36528041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplant benefit-based offering of deceased donor livers in the United Kingdom.
    Allen E; Taylor R; Gimson A; Thorburn D
    J Hepatol; 2024 Mar; ():. PubMed ID: 38521169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.